logo
Essity Included in S&P Global Sustainability Yearbook 2025 and Dow Jones Sustainability Index

Essity Included in S&P Global Sustainability Yearbook 2025 and Dow Jones Sustainability Index

Originally published on Essity News Center
The hygiene and health company Essity has, for the fourth consecutive year, been included in S&P Global's Sustainability Yearbook. The company is ranked industry best in the Household Products category. Additionally, Essity has been listed in the Dow Jones Sustainability Index (DJSI), one of the world's most prestigious sustainability indices.
S&P Global is an international finance and analytics company that annually evaluates and lists the world's most sustainable companies. Each company responds to a comprehensive questionnaire that is evaluated alongside public data on environmental, social, and governance issues.
To be included in the Sustainability Yearbook, a company must rank among the top 15 percent in its industry. In a global review of 7,690 companies, Essity is best in its industry, Household Products, and part of the top 1 performing percent in this year's edition of the Sustainability Yearbook.
In the DJSI, which is part of S&P Global, Essity is included in the DJSI Europe and DJSI World indices. Among the world's 2,500 largest companies, Essity is found in the top 10 percent in terms of sustainability performance. The evaluation is based on long-term economic, environmental, and social criteria. The DJSI is the first global sustainability index and was launched in 1999.
For further information, please contact: Karl Stoltz, Public Relations Director, +46 (0) 709 426 338, [email protected]
About Essity Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2024, Essity had net sales of approximately SEK 146bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Buy Palo Alto if it sees a post-earnings sell-off, according to this chief investment officer
Buy Palo Alto if it sees a post-earnings sell-off, according to this chief investment officer

CNBC

time7 minutes ago

  • CNBC

Buy Palo Alto if it sees a post-earnings sell-off, according to this chief investment officer

Palo Alto Networks will post earnings Monday afternoon and a buying opportunity may emerge, according to Michael Landsberg, investment chief at Landsberg Bennett Private Wealth Management. Investors should be ready to snap up the stock if it sees some pressure following the results, he said. Landsberg joined CNBC's " Power Check " Monday to offer his insights on Palo Alto and a couple other trending stock stories. Here is what he had to say. Palo Alto Networks Shares of the cybersecurity company have seen meaningful weakness in recent months, pulling back more than 15% over the past six. Landsberg said that any further weakness after its quarterly results would provide an opportunity for investors. "Cybersecurity is one of those businesses that continues to keep moving forward," he said. "The smarter [artificial intelligence] gets, the smarter AI cybersecurity has to get." "The stock should I think hopefully trade off a bit for people that don't own it," the CIO also said, adding that investors "should be a buyer" of the name if it reports 16% year-over-year earnings per share growth. Landsberg disclosed that he's held the stock for 10 years and predicts holding it for another five to seven years, seeing that "it's been a real winner." Viking Holdings Landsberg is also taking a bullish approach to cruise name Viking Holdings ahead of its earnings results on Tuesday before the bell. He said thinks that the company will report earnings growth of 32% year over year and believes this trend will continue. "Viking has done a really good job of marketing themselves to higher-end consumers," he said. "They go to every continent in the world, and it's a smaller boat. It's a smaller bespoke experience, so you're not competing with thousands and thousands of people on these boats. I think people like that. They want to have that high-end experience." Landsberg said that while he doesn't own shares of the company right now, he'll want to own it in the future. This comes as the stock has soared more than 37% year to date, outperforming the S & P 500's rise of almost 10% in the period. "I own the entire space," he added. "We think it's a good name." Estee Lauder While shares of Estee Lauder have also seen gains recently, surging more than 39% in the past three months, Landsberg was more cautious when it came to the cosmetics giant, saying that the name is "tricky." "There's a lot of cosmetics companies in the world," he said. "Estee Lauder hasn't grown their earnings or their revenue in probably four-plus years. Lots of competition, and my fear is just there's so much, there's so many choices out there. It's really tough." The company is due to post its quarterly results before market open on Wednesday, and Landsberg thinks the results could mark a bottom for earnings if they're down 85% year over year. "Maybe this is the bottom that you could be a buyer down the road," he also said. "We don't own it. We're not going to own it, but I'm hoping at some point. They've got good quality brands." "The stock's been kind of one of those things that earnings wise, it just doesn't make the money that excites us to be able to step in," Landsberg added.

These stocks offer rising dividends and the prospect of higher returns, Morgan Stanley says
These stocks offer rising dividends and the prospect of higher returns, Morgan Stanley says

CNBC

time7 minutes ago

  • CNBC

These stocks offer rising dividends and the prospect of higher returns, Morgan Stanley says

Even as the market trades near record highs, dividend payers – particularly those that have lifted their payments – can bolster portfolios in rocky times. The S & P 500 touched a fresh all-time high on Friday, and it has surged 9.6% in 2025. The broad market index is up more than 30% from its April low, back when the Trump administration announced a slate of tariffs that rattled investors. Dividend-paying stocks can offer investors some measure of safety from these jolts, though. "In periods of elevated risks and valuations, dividends become [a] more important part of investors' total returns, dampening volatility and providing some support to stock prices," wrote Morgan Stanley strategist Todd Castagno in a Thursday report. Higher dividend yields that are durable are also attractive during times of slowing growth and falling interest rates, he added. Not all dividend payers are built equally, though. Yields that are unusually high could imply that the stock price is on a downward trajectory, and dividends that are unsustainable could ultimately be slashed if a company falls on hard times. Castagno's team screened through the Russell 1000 for companies with a dividend yield of at least 0.25% and a quarter-over-quarter dividend hike of at least 15% over the last 12 months. Here are a few of the names that turned up. Software giant Oracle made the cut on Morgan Stanley's list. The stock offers a modest current dividend yield of 0.8%, but shares are up about 49% in 2025. In June, the company posted fiscal fourth-quarter results that surpassed expectations. Forward guidance was rosy, with CEO Safra Catz anticipating more than $67 billion in fiscal 2026 revenue, compared with the LSEG consensus of $65.18 billion. Mizuho analyst Siti Panigrahi lifted the firm's price target on Oracle to $300 from $245 on Friday, pointing to the company's emergence as a structural artificial intelligence winner. "With its end-to-end AI stack, spanning vertical and horizontal applications, mission-critical database technology, and infrastructure for AI training/inference, Oracle is well positioned to capture a disproportionate share of AI-driven enterprise spend over time," Panigrahi wrote. The analyst noted that AI momentum is "paving the path to the trillion-dollar club." Analysts like the stock, with 29 out of 42 rating it a buy or strong buy, per LSEG, but the average price target of $247.23 implies Oracle shares' upside could be limited. American Homes 4 Rent also turned up on the firm's screen. Shares of the real estate investment trust, which focuses on single-family rentals, are down nearly 8% in 2025. The stock has a current dividend yield of 3.5%. Mizuho analyst Haendel St. Juste stuck with his outperform rating last week, but trimmed back his price target to $36 per share from $38. "All-around execution and higher development yields drive FY25 core portfolio and [funds from operations] guidance raise," he wrote. Funds from operations , or FFO, reflects how much cash flow a REIT generates from its business. American Homes recently lifted its FFO guidance for 2025 to a midpoint of $1.86 per share, up three cents – thanks in part to better-than-anticipated development yields, St. Juste wrote. Thirteen out of 24 analysts covering the stock rate it a buy or strong buy, and consensus price targets call for 18% upside, per LSEG. Morgan Stanley also highlighted wireless communications giant T-Mobile . The stock is up 16% in 2025 and has a dividend yield of 1.4%. The firm is also bullish on T-Mobile, with Morgan Stanley analyst Benjamin Swinburne rating the stock overweight. He did, however, trim his price target to $265 from $280 last month. The move was "mainly to address the overhang of secondary stock sales." In all, 18 out of 31 analysts covering T-Mobile see it as a buy or strong buy, but consensus price targets suggest just 5% upside from current levels, per LSEG. — CNBC's Michael Bloom contributed reporting.

Morning Movers: Dayforce surges after potential Thoma Bravo acquisition reports
Morning Movers: Dayforce surges after potential Thoma Bravo acquisition reports

Business Insider

time44 minutes ago

  • Business Insider

Morning Movers: Dayforce surges after potential Thoma Bravo acquisition reports

Stock futures are drifting lower this morning as investors lean into a busy week headlined by Jackson Hole central bank speeches and earnings from major retailers. Small caps are showing outperformance, suggesting rotation after recent megacap strength, particularly in tech. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Geopolitical developments are adding weight as markets are monitoring the potential implications of President Trump's meeting with Ukrainian President Zelensky and European leaders as Washington seeks support for a Ukraine–Russia peace initiative. In pre-market trading, S&P 500 futures fell 0.09%, Nasdaq futures fell 0.14% and Dow futures are flat. Check out this morning's top movers from around Wall Street, compiled by The Fly, and subscribe to the Fly By if you want to know how the markets will open, which stocks will be moving and why. HIGHER – Dayforce (DAY) up 25% after Bloomberg reported Thoma Bravo is in talks to acquire the company Soho House (SHCO) up 16% after entering into definitive agreements pursuant to which an investor group led by MCR and its chairman and CEO Tyler Morse will acquire the outstanding shares not held by certain significant shareholders TeraWulf (WULF) up 11% after reporting Google (GOOGL) will provide an incremental backstop of $1.4B in support of project-related debt financing and will receive warrants to acquire shares of TeraWulf common stock Tonix Pharmaceuticals (TNXP) up 4% after announcing that the FDA approved Tonmya for the treatment of fibromyalgia in adults Novo Nordisk (NVO) up 4% after announcing that the FDA has approved an additional indication for Wegovy based on a supplemental New Drug Application for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis in adults with moderate to advanced liver fibrosis DOWN AFTER EARNINGS – Riskified (RSKD) down 13% LOWER – Strategy (MSTR) and Coinbase (COIN) both down 1% after bitcoin dipped as heightened macro concerns triggered more than $500M in forced selling of long positions. Tesla (TSLA) down 1% after The Times reported British motorists can lease a Tesla EV for about half the cost it was a year ago as the company attempts to boost its faltering sales in the UK

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store